Top 50 Biotech Startup Investors in Sweden in December 2024
A list of 50 angel investors and VC (Venture Capital) funds that invest in Biotech startups based in Sweden. We rank investors based on the number of investments they made in Biotech companies from Sweden. We update this investor list every month.Top 50 Biotech Startup Investors in Sweden in December 2024
Investor | Biotech Sweden investments |
---|---|
Sciety | 14 |
Chalmers Ventures AB | 13 |
Industrifonden | 10 |
Almi Invest | 10 |
Karolinska | 5 |
Navigare Ventures | 5 |
SEB Venture Capital | 4 |
Norrsken VC | 4 |
HealthCap | 4 |
Partnerinvest Norr | 3 |
Novo Holdings | 3 |
Inventure | 3 |
Crowberry Capital | 3 |
Hadean Ventures | 2 |
Voima Ventures | 2 |
EIR Ventures | 2 |
Boehringer Ingelheim Venture Fund | 2 |
BackingMinds | 2 |
Noaber | 2 |
Segulah Medical Acceleration | 2 |
Andreas Ehn | 2 |
LIU Invest | 2 |
Nina Capital | 2 |
Ferd | 1 |
GU Ventures | 1 |
Sätila Holding | 1 |
Flerie Invest | 1 |
Nordic Foodtech VC | 1 |
Impilo | 1 |
Teknoinvest | 1 |
LUBio Science | 1 |
Fåhraeus Startup and Growth | 1 |
Irrus Investments | 1 |
PULS | 1 |
Ackra Invest | 1 |
Innovations Kapital | 1 |
Nxt2b | 1 |
Porte Monnaie | 1 |
Hampus Jakobsson | 1 |
Bonnier Ventures | 1 |
Simon Fredriksson | 1 |
SmiLe Inject Capital | 1 |
TPG Growth | 1 |
Josefin Landgård | 1 |
Inter Ikea | 1 |
Fibonacci Growth Capital | 1 |
LU Holding | 1 |
European Investment Bank | 1 |
Landegren Gene Technology | 1 |
Länsförsäkringar | 1 |
Whether you are an investor or entrepreneur, partner with Sciety to achieve impactful returns and elevate your life science business in the Nordics.
Show more
Investment focus
- Health Care, Biotechnology, Pharmaceutical
- Seed, Series A, Funding Round
- Sweden, Ukraine
Portfolio highlights
- NEOGAP Therapeutics — NEOGAP Therapeutics is a clinical-stage biopharmaceutical startup focused on immuno oncology. Their pharmaceutical product, personalized tumor trained lymphocytes, offers even one customized cell treatment that is meant to precisely target and destroy cancer in a tailored environment, with very minor side effects.
- PharmNovo — Latest News from PharmNovo. Learn more about pain, neuropathic pain, chronic pain. Treatment with our lead candidate PN6047. Therapy market, our networks. There is a huge unmet medical need for people suffering from chronic pain.
- Capitainer — Quantitative microsampling solutions for diagnostics, research and clinical trials. Microsampling you can trust.
We are a leading tech investor & venture builder in the Nordics. Taking deep tech from lab to market.WELCOMEINVESTMENTS
Show more
Investment focus
- Software, Health Care, Energy
- Pre-Seed, Seed, Funding Round
- Sweden
Portfolio highlights
- Eneryield — We are specialized in predicting power outages with Sensorless Explainable AI. This enables proactive meassures.
- Korall Carbon Capture — Korall Carbon Capture is a pioneering company in Sweden specializing in Direct Air Capture (DAC) technology. KORALL offers a product in the form of a chemical blend that actively captures carbon dioxide as soon as it comes into contact with the air.
- ZeroPoint Technologies — ZeroPoint Technologies AB was created in 2016 as a spinout from Chalmers University of Technology. The Intellectual Property Portfolio related to computer memory management was the acquired from the University and transferred into a new startup.The Technology, ideas and many of the people behind and with ZeroPoint comes from Professor PerStenströms research group, which is internationally recognized for excellence within high-performance Computing. Since its creation, ZeroPoint has attracted skilled people from industry, finance and the startup community and raised its’ first round of Venture Capital in 2016.
Industrifonden is a Nordic evergreen venture capital firm with a fund size of $600m, that focuses on early-stage technology and life science companies with international potential. The company works long term with the entrepreneurs we invest in, and have a strong track record of building game changing companies. Industrifonden-backed companiesinclude tech companies Qlik, Arcam, Soundtrack Your Brand, Fishbrain, and life science companies CellaVision, Oncopeptides and AMRA.
Show more
Investment focus
- Software, Biotechnology, Information Technology
- Funding Round, Series A, Seed
- Sweden, United States, Denmark
Portfolio highlights
- Arevo — Arevo offers liquid and granular amino acid fertilizer technologies for faster and better plant establishment.
- Telness Tech — We help telcos maximize customer happiness and minimize OPEX through automation. Our proprietary, cloud-based, end-to-end BSS/OSS platform is connectivity ready in 64 countries.
- ZeroPoint Technologies — ZeroPoint Technologies AB was created in 2016 as a spinout from Chalmers University of Technology. The Intellectual Property Portfolio related to computer memory management was the acquired from the University and transferred into a new startup.The Technology, ideas and many of the people behind and with ZeroPoint comes from Professor PerStenströms research group, which is internationally recognized for excellence within high-performance Computing. Since its creation, ZeroPoint has attracted skilled people from industry, finance and the startup community and raised its’ first round of Venture Capital in 2016.
ALMI Invest is a venture capital company which invests in Swedish companies with exciting, scalable business models and motivated entrepreneurs. ALMI Invest consists of eight regionally based venture capital funds, all with local offices and experienced local investment managers. We manage a total of SEK 1 billion.
Unlike most venture capitalists,we can invest in a wide range of businesses. A strong team of entrepreneurs, a scalable business model and an initial revenue stream are more important than the line of business when we invest.Our first, initial investment would typically be SEK 2-4 million. During the lifetime of an investment, sums of up to SEK 10 million can be ventured. We always syndicate with an investment partner (another venture capitalist or angel investor) from Sweden or otherwise which means that we can take a maximum of 50 percent of an investment round.ALMI Invest was founded in 2009 by ALMI Fretagspartner together with regional investors. Half of our capital comes from European Union structural funds, which accounts for an investment of SEK 500 million. The other 50 per cent comes from regional investors and ALMI Fretagspartner.
Show more
Investment focus
- Software, Health Care, Information Technology
- Funding Round, Seed, Pre-Seed
- Sweden, United States, United Kingdom
Portfolio highlights
- FLOX — Transforming global wildlife interactions with autonomous technologies. From fields to airports, we redefine boundaries for coexistence.
- RemotiveLabs — RemotiveLabs is a developer of an automotive software development platform designed to streamline the vehicle manufacturing process.
- GAIA BioMaterials — GAIA BioMaterials is the manufacturer of a bio-degradable product that offers pouch, tray, and bottle products.
Karolinska Development aims to create value for patients, researchers, investors and society by developing innovations from world class science into products that can be sold or out-licensed with high returns. The business model is to: SELECT the most commercially attractive medical innovations; DEVELOP innovations to the stage where the greatestreturn on investment can be achieved; and COMMERCIALIZE the innovations through the sale of companies or out-licensing of products.Karolinska Development has developed a well-structured selection process to identify the most commercially attractive medical innovations screened by KIAB. Pharmaceutical development is a high-risk enterprise. In most cases, development projects fail because of side effects or insufficient efficacy. Successful selection of innovations is fundamental to Karolinska Development’s business model, which makes the inflow of new projects crucial. One key to success lies in selecting those innovations that can be developed from scientific findings to products and have significant commercial potential. To date, over 1,300 projects have been screened by KIAB.The portfolio companies are often founded together with the innovators and are initially operated as virtual companies with few or no employees. During the first six to twelve months, the companies normally have minimal fixed costs and technological development is outsourced.The innovator, who is often employed at an academic institution, normally participates as a board member and scientific advisor. The CEO of a portfolio company cooperates closely with a representative of Karolinska Development, who in most cases is also a board member of the company. The companies are capitalized to reach their next milestone, usually within a period of six to eighteen months. Development projects are continuously monitored, and those that do not meet their stipulated targets are discontinued. In the first three to four years, a portfolio company’s operating expenses are often limited to a few million Swedish kronor per year, which cover the cost of external studies and the salary of the staff. In subsequent years, Karolinska Development and other investors play an important role recruiting key expertise to the companiesKarolinska Development intends to realize value by exiting portfolio companies or through out-licensing of projects. Such transactions (especially out-licensing) are often structured as single upfront payments followed by payments based on predetermined milestones and royalties on sales. Although Karolinska Development has a flexible exit strategy, pharmaceutical products are, for two reasons, preferably exited at Phase II. First a successful Phase II study indicates that the pharmaceutical has an effect on patients, which is an important value-enhancing factor when negotiating out-licensing or sales. Secondly, finalizing product development and undertaking Phase III clinical trials frequently requires very large patient populations. In many cases this requires much greater resources than those available at Karolinska Development but these can be found in established pharmaceutical companies. Several licensing deals were closed in 2011 involving projects with a similar focus and development phase to Karolinska Development's projects.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Funding Round, Seed, Series A
- Sweden, Denmark, United States
Portfolio highlights
- PharmNovo — Latest News from PharmNovo. Learn more about pain, neuropathic pain, chronic pain. Treatment with our lead candidate PN6047. Therapy market, our networks. There is a huge unmet medical need for people suffering from chronic pain.
- OssDsign AB — Giving patients back the life they deserve, Catalyst nanosynthetic bone graft, orthobiologics
- Modus Therapeutics — Modus Therapeutics is a Swedish drug development company developing sevuparin – a novel drug to treat people suffering from Sickle Cell Disease – a painful, inherited blood disorder affecting millions of people around the globe.
SEB Venture Capital is a Fintech investor that helps entrepreneurs and innovators launch and grow profitable businesses. They primarily serve as a strategic corporate venture focused on Fintech investments, with the option of partnering with SEB. They are also on the hunt for game-changing inventive solutions to new technologies that will make thefinancial industry smarter, safer, and more environmentally responsible, as well as more user-friendly. They also function as an evergreen fund, giving them the flexibility and staying strength to focus on long-term wealth development depending on what is best for the firm and its shareholders.
Show more
Investment focus
- Software, Information Technology, Financial Services
- Funding Round, Series A, Series B
- Sweden, Denmark, United Kingdom
Portfolio highlights
- Airsonett — Research-based medical technology company which leads the way in the development of non-pharmaceutical treatment for allergic asthma.
- EnginZyme — EnginZyme is a biotechnology company that specializes in biocatalysis. It creates products for easy and cost-efficient implementation of biocatalytic processes and helps the chemical industry transition to a sustainable way of operating.The company is driven by a mission to make biocatalysis the first choice for chemical process designersworldwide.
- Qvantum — Qvantum is driven by a passion for a sustainable future and we are changing the way the cities of Europe are heated.
We are a venture capital fund investigating in Start-Ups solving the worlds biggest problems while building massive businesses.
Show more
Investment focus
- Software, Health Care, Food and Beverage
- Seed, Series A, Funding Round
- Sweden, United Kingdom, Germany
Portfolio highlights
- Aerleum — Aerleum transforms CO2 into clean fuels and chemicals. Discover our innovative technology and mission to decarbonize hard-to-abate industries for a sustainable future.
- juna.ai — AI Agents to Run Your Factory
- terralayr — At terralayr, we're not just offering storage and batteries; we're pioneering a new era of energy flexibility. In a world where renewable energy is on the rise, the need for flexibility in energy storage has never been more crucial. That's where we come in.
HealthCap, a life science investor and company creator. Our motivation is to find innovative ideas and invest that could impact healthcare and society.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series B, Series A, Funding Round
- United States, Sweden, France
Portfolio highlights
- Kivu Bioscience — At Kivu Bioscience, we leverage advanced, next-generation proprietary ADC technologies to deliver more precise and effective cancer treatments.
- Rampart Bioscience — Rampart Bioscience develops gene medicines to provide long-lasting treatments for a wide range of diseases. It also offers proprietary development and delivery platforms, which together, create optimized therapeutics in a revocable, non-viral format. It also assists patients with genetically driven diseases by integrating capabilities from avariety of key scientific disciplines including gene delivery, protein sciences, and clinical translation.
- SynOx Therapeutics — SynOx Therapeutics is a biotechnology research company that focused on developing the treatment of diffuse tenosynovial giant cell tumors. SynOx Therapeutics raises EUR 37m to develop emactuzumab to improve the lives of patients with tenosynovial giant cell tumors November 16, 2020. It was founded in 2020 and is located in Dublin City, Ireland.
Partnerinvest Norr is a private equity firm specialized in software, security, and biometrics sectors.
Partnerinvest Övre Norrland AB is a venture capital firms that seeks to invest in limited companies which have are in the expansion phase.
Show more
Investment focus
- Software, Information Technology, Manufacturing
- Seed, Funding Round, Series A
- Sweden, United States
Portfolio highlights
- Flasheye — Flasheye has proven technology from the automotive, defense, and robotics industries into industrial applications.
- Elastisys — Succeed with your cloud native journey as an organization developing and operating software critical to our society. NIS2, ISO-27001, GDPR.
- Nordic Quick Systems — Nordic Quick Systems have been developing sprockets with segments that can be rotated and replaced. With their solution, machine maintenance can be carried out while both the chain and wheel body remain on the conveyor. Their products are developed in northern Sweden, a region strongly associated with well-qualified heavy industry. They work fortheir patented sprocket to become a new industry standard that streamlines the industry.
Novo Holdings is a world-leading life science investor with a focus on creating long-term value.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Series B, Series C
- United States, Denmark, United Kingdom
Portfolio highlights
- ADCendo — ADCendo ApS is a biotech company dedicated to developing new types of anti-cancer drugs. We focus on antibody-drug conjugates (ADCs) directed at novel targets, that have been found to be overexpressed by several cancer forms, that are all characterized by a significant unmet need for novel treatment.
- Antag Therapeutics — Antag Therapeutics operator of a biotechnology company intended to develop metabolic and anti-obesity therapeutic drugs.The company specializes in the development of peptide-based GIP receptor antagonist in order to monitor dietary-related metabolic diseases through the infusion, enabling the healthcare industry to decrease blood flow and lipiduptake in adipose tissue in an efficient manner.
- Nuvig Therapeutics — Nuvig Therapeutics is advancing innovative and transformational therapies that are designed to induce natural mechanisms to restore immune homeostasis, rebalance immune function following inflammation, and improve the treatment options for patients. Nuvig is building a pipeline of novel immune therapeutics for chronic inflammatory and autoimmunediseases.
Since 2005, Inventure has backed over 90 companies including Wolt, Swappie, Jobbatical, aiMotive, and more.
Show more
Investment focus
- Software, Information Technology, Health Care
- Seed, Series A, Series B
- Finland, Sweden, Denmark
Portfolio highlights
- Steep — Business intelligence for modern companies. Steep lets anyone on your team stay on top of your data.
- Moncyte Health — Unique technology and novel data for personalized and optimal treatment of high cholesterol
- Avenue Biosciences — From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.
Crowberry Capital invests at seed and early stage in emerging technology ventures in the Nordics. Our mission is to back people that are good for companies and build companies that are good for people. We have a strong follow-through philosophy and commit to putting your company first.
Show more
Investment focus
- Software, Gaming, Health Care
- Seed, Series A, Pre-Seed
- Iceland, Denmark, Finland
Portfolio highlights
- Tiimo — Tiimo helps you manage your daily life and improve your wellbeing. Visualize your day. Improve your routines. Stress less.
- Quanscient — We are building next generation simulation software-as-a-service utilizing Quantum computing algorithms. Our specialty domain of simulations is Computational Electromagnetics.
- Porcelain Fortress — Porcelain Fortress was founded by a small band of romantics in the summer of 2016 in Reykjavik, Iceland.
Hadean Ventures is a life science fund manager that invests in life science companies across europe with a particular focus on the nordic region.
The funds are backed by leading private and institutional investors.
Hadean Ventures has offices in oslo and stockholm and collaborates with world-class academic institutions and start-up hubs across theregion
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Funding Round, Series B
- Sweden, Norway, Austria
Portfolio highlights
- SciRhom — SciRhom GmbH is a biotech company that translates science into the preclinical and early clinical development of novel biopharmaceuticals for the treatment of life-threatening autoimmune diseases. Based on longstanding academic research and a well-established network of experts, SciRhom was founded in 2016 through a collaboration between academicand industry scientists with profound experience in antibody development.
- Alex Therapeutics — The Alex DTx Platform enables partners within pharma and health care to effectively and reliably launch new DTx treatments by leveraging existing insights, modules, processes and data.
- TargED Biopharmaceuticals — TargED Biopharmaceuticals is a biotechnology company that develops first-in-class biological drugs to improve treatment of thrombosis.TargED stands for Targeted Enzyme Delivery. Their biological drugs are unique by using small antibodies (“VhH”) to deliver enzymes to sites of thrombosis, enabling ‘targeted’ thrombolysis.
Voima Ventures’ mission is to solve major global problems by combining science, entrepreneurship, and value adding capital. They shed light on the ideas and technology which require time and courage to build. Industry domains include bio and new materials, medical technologies and life sciences, imaging and optics, IoT and electronics, robotics,software & ICT and AI. In addition, Voima Ventures has invested in more than 30 deep tech startups, including companies like Solar Foods, Infinited Fiber Company, and Dispelix. Cornerstone investors are VTT Technical Research Centre of Finland and European Investment Fund (EIF), backed by Finnish private and institutional investors.
Show more
Investment focus
- Biotechnology, Health Care, Medical Device
- Seed, Pre-Seed, Funding Round
- Finland, Sweden, Norway
Portfolio highlights
- NADMED — The standard of NAD measuring
- Betolar — Betolar is a new materials startup specialized in new geopolymer-based carbon-neutral construction materials for the construction industry and circular economy.
- Avenue Biosciences — From biotechnology tools to therapy discovery and development: Our platform enhances production yield and the quality of your end product.
EIR Ventures is a new Life Science Venture Group in the Nordics.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Seed, Funding Round
- Denmark, Sweden, United States
Portfolio highlights
- Henlez — Henlez is a Danish startup company.
- ArgusEye — ArgusEye - Innovative Sensor Solutions - Real-time monitoring and control of biological systems and processes - Patented sensor technology
- Moleculent — Moleculent is adding a functional layer of biology to pave the way for unparalleled advancements in biological research.
The Boehringer Ingelheim Venture Fund is the strategic venture fund of the Boehringer Ingelheim Corporation.
Show more
Investment focus
- Biotechnology, Health Care, Therapeutics
- Series A, Series B, Seed
- United States, Germany, Belgium
Portfolio highlights
- Aignostics — Aignostics is an AI-powered precision diagnostics focused on pathology to assist with drug development and clinical research. Its “explainable” AI overcomes the “black-box” limitations of conventional AI. Based on their patented technology for reverse-engineering the black box, they render diagnostic results explainable in the form of preciseheatmaps and image overlays. These heatmaps allow pathologists to quickly verify the results of the AI, which is crucial, as the pathologist is ultimately responsible for the diagnosis.The company was founded in 2018 and is headquartered in Berlin, Germany.
- Glox Therapeutics — Developing novel precision antibiotics based on protein bacteriocins, to target Gram-negative Antimicrobial Resistant (AMR) pathogens.
- Asgard Therapeutics — Asgard Therapeutics is a private biotech company exploring the application of direct cell reprogramming technologies for cancer immunotherapies. Formed as a spin-off from Lund University, the Company is pioneering a gene therapy approach based on its proprietary TrojanDC technology, designed to set in motion immune responses based on the biologicalproperties of professional antigen-presenting cells.
We help great minds unleash their full potential!
Show more
Investment focus
- Medical Device, SaaS, Information Technology
- Seed, Funding Round, Pre-Seed
- Sweden, Denmark, Finland
Portfolio highlights
- Uniqkey — Uniqkey provides a security management platform that automates employee logins to make businesses secure and productive. It simplifies employee security while empowering companies with enhanced control over their cloud infrastructure, access security, and employee management.Recognized as the easiest tool, Uniqkey removes friction from employees’daily workflows by automating time-consuming authentication and security tasks, thereby increasing productivity. Its intuitive and user-friendly interface makes Uniqkey the perfect choice for employees.Uniqkey combats the most significant threats to company infrastructure by safeguarding critical systems and company credentials with state-of-the-art encryption. It also offers unique insights and a comprehensive view of IT infrastructure, employee access, and security scores, making it a valuable tool for IT teams to monitor security policies and confidently assess the impact of awareness campaigns.With powerful integrations and synergies with existing infrastructure such as Microsoft, IT managers can quickly provision or de-provision users for seamless onboarding and offboarding, all while protecting their entire IT infrastructure with advanced encryption.Trusted by 500+ European businesses and ranked as a Top 50 Global Security Solution by G2, our platform is becoming Europe's preferred business password and access management solution.
- NitroVolt — NitroVolt: the next generational step of sustainable ammonia.
- Serviceform — Welcome to future of communication - the truly all-in-one conversion and management software built for established businesses. Start now!
Noaber Ventures invests in initiatives that bring social transformations using information technology.
Show more
Investment focus
- Health Care, Medical, Fitness
- Seed, Series A, Funding Round
- The Netherlands, Israel, Sweden
Portfolio highlights
- Newsenselab (M-sense) — M-sense is a certified medical app to combat migraines and headache. Our goal is to reduce 50% of headache days through a personalized therapy program - all in-app.
- Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
- Alba Health — Discover your baby's gut health & microbiome for the best start in life.
Segulah Medical Acceleration is a Scandinavia-based investment company focusing on innovative medical technology companies in Europe.
Show more
Investment focus
- Health Care, Medical Device, Biotechnology
- Series A, Series D, Series B
- Sweden, Germany, United States
Portfolio highlights
- Protembis — ProtEmbo is designed to be a simple and reliable solution for one of the most feared complications during TAVR.The advent of transcatheter treatments for valvular heart disease has been a major revolution in the care of patients with disabilities or intercurrent illnesses that precluded undergoing stressful open cardiac surgical procedures.Nonetheless, in spite of ongoing improvements in TAVR procedures and outcomes, the occurrence of cerebrovascular events represents a significant morbidity of TAVR.Protembis was founded based on the vision to reduce the risk of cerebrovascular events, thereby improving outcomes and making TAVR even safer – especially in light of TAVR shifting to younger and lower-risk patients. The ProtEmbo System is an adjunctive device used during TAVR and removed following completion of valve implantation. The ProtEmbo is an intra-aortic filter device that is designed to deflect embolic material arising during TAVR away from the cerebral circulation.
- Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
- Signifier Medical Technologies — Driving Innovation in the Sleep MarketSignifier Medical Technologies (SMT) is a medical technology company focused on the development and commercialisation of innovative and non-invasive solutions for patients with sleep-disordered breathing conditions and snoring. Pioneers in challenging the wisdom of conventional sleep apnoea and snoring treatments, we've created the first daytime therapy that tackles the root cause of sleep-disordered breathing by physiologically retraining the airway against collapse.
Andreas is working on a service that will connect people, time and places on the web. He also works as an independent consultant helping other startups with product strategy, technical infrastructure, scalability and recruiting as well as financial companies (venture capital and private equity) with technical due diligence and in other advisorroles.He was CTO at Spotify from the launch of the company in August 2006 until November 2009. Before that he worked at Stardoll as an engineer and project manager.
Show more
Investment focus
- Software, Internet, Financial Services
- Seed, Angel, Pre-Seed
- United States, Sweden, Germany
Portfolio highlights
- Prog.AI — Prog.AI helps to find developers based on their technical proficiency, libraries they have used, or even just the contributions they have made to GitHub projects.
- Red Flag — Red Flag develops an automated accounting, expenses, and invoicing platform for SMEs.
- Single Technologies — Founded in Stockholm, Sweden, with its long tradition in fiber optics, ultra-sensitive fluorescence spectroscopy and DNA sequencing, SINGLE’s ambition is to become the instigator of 3-D Sequencing.
LIU invests in companies that are based on projects and ideas from Linköping University. LIU Invest is focused on investments in early phases. Investments are typically 250 000, but can be doubled by an additional investment.
Show more
Investment focus
- Biotechnology, Information Technology, Health Care
- Funding Round, Seed, Pre-Seed
- Sweden
Portfolio highlights
- Cellfion — Cellfion provides sustainable materials for next level clean energy storage and conversion devices.
- Epishine — Epishine's goal is to be able to provide the world's most scalable, resource efficient, and affordable solar modules. Epishine sells light energy harvesting modules to manufacturers of wireless products. The modules are used to harvest light in any lighting conditions, turning light into usable power.
- LunaMicro — Technology company developing textile pumps based on electroosmosis and conducting polymers for a wide variety of applications including outdoor clothing, PPE, and medicine.
We deploy early stage capital to fuel the growth of need-driven health technology companies.
Show more
Investment focus
- Health Care, Artificial Intelligence, Software
- Seed, Pre-Seed, Series A
- United States, United Kingdom, Austria
Portfolio highlights
- Noah Labs — Noah Labs is a compant that creates AI-powered software solutions for medical care and research that help diagnose, manage illnesses, and guide interventions.
- Rivia — Integrated Clinical Trial Intelligence. Drive therapeutic evaluation and trial management with real-time insights.
- Lillian Care — Lillian is building a nationwide network of health facilities in Germany.
Ferd er et familieeid investeringsselskap som er eid av femte og sjette generasjon Andresen.
Show more
Investment focus
- Energy, Software, Manufacturing
- Funding Round, Private Equity, Post-IPO Equity
- Norway, Sweden, United States
Portfolio highlights
- Ludenso — Ludenso is a software developer of AR solutions for the education industry. To make education more creative and engaging, we are giving editors, authors, and teachers the power to bring their learning resources to life through 3D models, animations, videos, and audio support. This is made possible through the Ludenso Studio, where they can createinclusive learning experiences that enables students to learn in their own way.
- wheel.me — The first and only autonomous wheel in the world. The innovation transforms anything into an autonomous mobile robot with minimal effort and without the need to alter its design or form. The company was founded in 2013 and is headquartered in Oslo, Norway.
- Nofence — Nofence is a system virtual fencing for grazing animals. Virtual fencing of livestock has been a concept long discussed in academia. The Norwegian ag-tech startup Nofence has since 2011 developed and patented a solution for virtual fencing that has proven to work. The customers say that this will become a real gamechanger for livestock managementsince pastures can easily be defined by a few clicks on a tablet/smartphone. The herd is then safely fenced in and can be monitored. The system will send notifications if something happens. From the global food security perspective, this solution will make it much easier to utilize the uncultivated land for varied and healthy pasture, and make it possible to produce more food on cultivated land.
GU Ventures build businesses out of groundbreaking ideas that help shape a better tomorrow. Our passionate team of company builders, financial experts, IP and legal talent ensure success for our companies.
Show more
Investment focus
- Health Care, Pharmaceutical, Eyewear
- Seed, Funding Round
- Sweden
Portfolio highlights
- OnDosis — An intuitive dosage manager that helps patients optimize their treatment outcomes. Closing the loop between patient and physician.
- Profundus Imaging — Profundus' retinal imaging technology enables researchers and clinicians in particular to visualise subclinical changes of retinal disease.
- Thioredoxin Systems — Thioredoxin Systems AB is developing an innovative antibiotic regimen for complicated urinary tract infections caused by antibiotic-resistant bacteria. The
On Sätila Holding, They are constantly looking for exciting new business ideas. They invest in start up, buy-out, expansion and reorganization. They go in as partners and their investments tend to be between 1 and 10 million.
Show more
Investment focus
- Biopharma, Health Care, Biotechnology
- Funding Round
- Sweden
Portfolio highlights
- Adenovir Pharma — Adenovir Pharma AB is a development company developing new solutions for treatment of infectious diseases affecting the eyes.Adenovir Pharma was founded by researchers at the department of Virology, UmeÃ¥ University, Sweden and P.U.L.S. AB which acts as an incubator and financer for early stage projects within life science. Adenovir Pharma islocated in Helsingborg Sweden in one of Europe’s premier biotechnology regions, Medicon Valley. The initial development has been conducted at the University of Lund, Department of Organic Chemistry and at the University of UmeÃ¥, Department of Virology and in collaboration with P.U.L.S. AB and external service providers.With unique patented technology and own product concepts, Adenovir Pharma aim to offer new treatments and business development opportunities to the pharmaceutical industry. The goal is to develop a new antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC).
Flerie is an active long-term life science investor, focusing on biotech and pharmaceutical investments globally.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Funding Round, Series B
- Sweden, Israel, Iceland
Portfolio highlights
- Microbiotica — Microbiotica is a developer of human microbiome therapeutics intended to discover and develop live bacterial therapeutics and biomarkers. The company's therapeutics identify gut bacteria linked to phenotype with unprecedented precision, enabling researchers to phenotype before testing of candidate bacteria in advanced human in vitro and invivo models.
- Synerkine Pharma — Synerkine Pharma. Connecting Cytokines for the benefit of patients.
- Vitara Biomedical — Vitara Biomedical has developed a therapeutic platform to support premature infants. Vitara Biomedical's platform was inspired by natural physiological processes to transform neonatal care.
We are investing in #FutureFood. Nordic FoodTech VC is the first fund in the Nordics investing explicitly in the future of food
Show more
Investment focus
- Biotechnology, Life Science, Water
- Seed, Series A, Funding Round
- Finland, Sweden, Denmark
Portfolio highlights
- Enifer — Enifer Bio is an expert at squeezing every last drop of value from biorefining operations. The solution is built on decades of Finnish expertise to allow the production of valuable protein-rich feed from streams previously considered worthless. The company has developed a new, sustainable production process for high-quality fish feed raw material.The company's method enables the efficient production of a single cell protein from fish by-products as a raw material for fish feed. The protein can replace soy, which is commonly used in fish feed and whose cultivation poses ecological challenges, such as deforestation in South America.
- EvodiaBio — EvodiaBio is a bio-industrial firm that creates natural, sustainable scents for the food and beverage industries. Founded in 2021 and is based in Copenhagen, Capital Region.
- NPHarvest — NPHarvest is a company with expertise in organic waste management, wastewater treatment, and nutrient recovery. NPHarvest is a research project aiming to enable efficient and profitable nitrogen recycling from waste flows to the fertilizer market, utilizing energy-efficient hydrophobic membrane stripping and ballasted sedimentation of phosphoruswith lime.
Impilo is a Nordic investment company focused solely on investments in companies operating in the pharmaceutical, medical technology, healthcare services and other health-related industries. Its starting point is that our portfolio companies must contribute to a positive and sustainable development of the communities and markets in which theyoperate in order to remain successful in the long term. It was founded in 2017 and is based in 2017 and is based in Stockholm, Sweden.
Show more
Investment focus
- Biotechnology, Pharmaceutical, Medical
- Funding Round
- Sweden, Denmark
Portfolio highlights
- Cavidi — Cavidi is Sweden’s leading supplier of viral load for HIV monitoring. Cavidi’s products enable efficient management of anti-HIV drugs (ARV therapy) so that people living with HIV can live a normal lifespan. Cavidi’s diagnostics reduce the cost of treatment and the spread of HIV. Cavidi also provides tools and kits for virus research to many of theworld’s leading labs.Cavidi is a Swedish biotech company founded as a spin-off from Uppsala University. Their expertise is based on understanding viruses and using this knowledge to create research tools and clinical diagnostics. Today their focus is on HIV but our methods and expertise can be applied to other viruses.Cavidi’s head office is in Uppsala, Sweden and they have sales offices in South Africa, India and USA. Their customers include hospitals, patient clinics, private laboratories, the pharmaceutical industry and research institutions worldwide.
- Scantox — Since 1977 Scantox has been a trusted partner for in-vivo preclinical research services for the pharmaceutical and medical device industries.
- Pelago Bioscience — We help you assess cellular Target Engagement. From Target Discovery to Preclinical Studies.
Teknoinvest is a premier Scandinavian venture capital company. They invest in areas of emerging technologies within the ITC and Life Sciences sectors. Their main geographical scope is Scandinavia and the USA. Teknoinvest was established as the first venture capital investment company. Teknoinvest is one of the most successful VC´s in Scandinaviaaccording to track record of value created for their investors.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Funding Round
- Sweden, Norway, United States
Portfolio highlights
- GLO — glō is a venture-backed company focused on the development and commercialization of advanced LED display products using nanotechnology. The unique nanotechnology is based on 11 years of research at Lund University’s Nanometer Structure Consortium. Headed by Professor Lars Samuelson, one of the world’s leading scientists in this field, who haspublished more than 500 papers related to this technology.glō's first office is in Lund, Sweden, where basic material research continues for the next generation nanotechnology. glō's research and product development along with pilot fabrication operation is carried out at glō-USA in Sunnyvale, California. In 2016, glō established an Asia office in Taipei, Taiwan, one of the largest and fastest-growing regions for LED lighting and display applications.glō's technology sidesteps the technical limitations of current planar LED technology. It allows for the creation of highly efficient, stable and ultimately unique red, green, blue (RGB) emitters out of one material system. It aims to achieve the industry’s best color stability and ultimately enables the growth of red, green and blue emitters on the same wafer. Highly-efficient white LEDs with high color rendering will be possible without the need for phosphor conversion. It is the next enabling technology for advanced display, illumination and automotive applications.glō nanowire light-emitting diodes (nLEDs) are based on its proprietary hetero-structured semiconductor nanowire epitaxial growth and process technologies for which standard manufacturing equipment and materials can be utilized.glō currently holds over 175 patents across US, Europe and Asia. These patents are not subject to any cross-licensing with the LED oligopoly. The glō team is constantly strengthening its intellectual property position in this technology and related applications.
- SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
- Sol Voltaics — Founded in 2007, Sol Voltaics AB is a venture-backed, development-stage nanotechnology company focused on development and commercialization of highly efficient, third-generation photovoltaic concentrator solar cells based on its proprietary heterostructured nanowire epitaxial growth and process technologies.
LubioScience is Switzerland's biggest Life Sciences distributor. 120+ high quality suppliers, 4.5 million research products. Next day carbon-neutral delivery.
Show more
Investment focus
- Therapeutics, Biotechnology, Medical Device
- Funding Round
- Sweden
Portfolio highlights
- Cantargia — The company is based on the original discovery that leukemic stem cells in patients with chronic myeloid leukemia (CML) express a cell-surface receptor, whereas corresponding normal hematopoietic stem cells do not express this receptor. Stem cells from patients with acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL) has also beenshown to have and upregulation of the receptor. Cantargia uses this receptor, the Interleukin-1 receptor accessory protein (IL1RAP), as the target for development of a novel antibody-based therapy for leukemia
Fåhraeus Startup and Growth is a venture capital fund that invests early in life science and tech companies.
Show more
Investment focus
- Medical, Health Care, Organic Food
- Funding Round, Seed
- Sweden
Portfolio highlights
- Saveggy — Saveggy develops a bio-based edible vegan coating for fruit and vegetables eliminating plastic while keeping its protecting properties.
- Airsonett — Research-based medical technology company which leads the way in the development of non-pharmaceutical treatment for allergic asthma.
- Nygen Analytics — Nygen empowers researchers to unlock insights from single-cell RNA-seq data with accessible, no-code solutions, facilitating reproducible transcriptomic research.
Irrus Investments is the leading Irish business angel network with international connections. Fueling Irish innovation in medical devices, software, hardware, digital healthcare and life sciences.
Show more
Investment focus
- Biotechnology, Health Care, Medical Device
- Seed, Funding Round, Series A
- Ireland, Sweden, United States
Portfolio highlights
- Ovagen — Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry& rodent research technologies to GMP standards and in avian transgenics.
- ByoWave — ByoWave has developed the Proteus Controller, a modular, accessible video game controller for disabled and non-disabled gamers.
- Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
PULS is specialized on DIN rail power supplies for industrial applications. We set standards in terms of efficiency, reliability, size and life time.
Show more
Investment focus
- Biopharma, Health Care, Biotechnology
- Funding Round
- Sweden
Portfolio highlights
- Adenovir Pharma — Adenovir Pharma AB is a development company developing new solutions for treatment of infectious diseases affecting the eyes.Adenovir Pharma was founded by researchers at the department of Virology, UmeÃ¥ University, Sweden and P.U.L.S. AB which acts as an incubator and financer for early stage projects within life science. Adenovir Pharma islocated in Helsingborg Sweden in one of Europe’s premier biotechnology regions, Medicon Valley. The initial development has been conducted at the University of Lund, Department of Organic Chemistry and at the University of UmeÃ¥, Department of Virology and in collaboration with P.U.L.S. AB and external service providers.With unique patented technology and own product concepts, Adenovir Pharma aim to offer new treatments and business development opportunities to the pharmaceutical industry. The goal is to develop a new antiviral medicinal product for the treatment and prevention of epidemic keratoconjunctivities (EKC).
Ackra Invest AB is a venture capital and private equity firm specializing in late venture, growth capital and turnaround investments. The firm does not have a sector preference and seeks to invest in small and middle sized companies based in Norrland; the Northern region of Sweden. It does not provide loans or invest in seed or early venture. Thefirm takes minority stakes, between 10 percent and 49 percent and invests between SEK1 million ($0.13 million) and SEK8 million ($1.02 million). It invests in equity or convertible loans and can perform co-investments. The firm seeks to exit its investments within seven years. Ackra Invest AB was founded in 2005 and is based in Skellefteå, Sweden.
Show more
Investment focus
- Manufacturing, Mining, Chemical
- Funding Round, Seed
- Sweden
Portfolio highlights
- Xore — Xore AB has develops and sells analyzers to enrichment plants in the mining industry.Xore is one of the world’s leading suppliers of on-stream analyzers and related services to the mining industry. Xore is the natural first choice when investing in equipment for on-stream analysis of pulp and liquids. Our product brand is Boxray™. Xore is agenuine Swedish engineering technology company based in Skellefteå in northern Sweden.
- Protab AB — Protab specializes in machining, turning and milling and manufactures details for the hydraulic and forest industry. Another important part of the business is system delivery, where the company also assembles the details that were manufactured.Protab manufactures components primarily for the hydraulics and forestry industries. System deliveries,where the company assembles manufactured components, form another important part of the operation. We also do value flow analyses to improve the efficiency of our customers' businesses. How can we make things better for you?
- Fortlax AB — Fortlax is Northern Sweden's data center with three world-class facilities just outside Piteå. We help companies grow using smart IT and cloud services. We store data in highest-class facilities at a location where risk analysis shows extremely low risk of natural disasters. In addition, we operate all our facilities with 100% green energy anduse natural cooling for large parts of the year. Fortlax AB has over the past fiscal year more than tripled its revenue and shows profit.
InnovationsKapital was founded in 1994 and is a leading independent venture capital firm for innovative growth companies in the Nordic region. The business, carried out from offices in and Stockholm, Gothenburg and New York, is focused on investments within ICT and Healthcare & Life Sciences, dynamic sectors that are rapidly expanding and whereNordic research plays an important role. The capital is provided by highly reputable Swedish and international institutional investors.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Funding Round, Series B, Series C
- Sweden, Denmark, United States
Portfolio highlights
- Silecs — PiBond manufactures materials used in electronic devices, including patterning materials for semiconductors and optical materials. We also develop complete solutions that allow our clients to focus on creating innovative products.
- SantoSolve — SantoSolve is developing topical analgesic products based on non-radioactive strontium as the active substance. The Development program was initiated based on experimental clinical use of strontium-based products showing evidence of strong local analgesic effects on several localized pain conditions of both nociceptive and neuropatic origin. Nosignificant adverse effects associated with the treatment was reported.The company’s lead product, 2PX, is topically administered, utilizing dermal penetration enhancers for delivery of the active agent to its subdermal site of action. Phase I safety and pharmacology studies showed the active agent to have low systemic bioavailability, and only few and minor adverse effects were observed at the site of administration. In open label Phase II clinical trials, the product has shown strong analgesic effect in both nociceptive and neuropatic pain conditions. In follow up, placebo controlled trials, the analgesic effect of the product has been further documented. In the company’s most advanced pain indication under study, osteoarthritis, the company has recently completed the Phase II program.These trials supports the open label results and document statistically that the analgesic effect in patients treated with 2PX is superior to that observed with placebo treatment.
- Action Pharma — Action Pharma A/S operates as a research and development focused biotechnology company. It discovers and develops new drugs and treatment concepts to treat cardiovascular disease and inflammatory diseases, as well as metabolic diseases, such as type-II diabetes and obesity. The company's product pipeline includes AP214, a modifiedÃMSH-peptide analogue for the treatment of post-surgical kidney injury associated with cardiac surgery; and AP1030 and AP11 series, oral anti-diabetic (OAD) for the treatment of type-II diabetes associated with overweight/obesity. Its product pipeline also comprise AP1189, an oral anti-inflammatory compound for the treatment of inflammatory diseases, such as inflammatory bowel disease and rheumatoid arthritis; and AP405, a modified MSH peptide analogue for the treatment of inflammatory skin diseases, such as atopic dermatitis. The company was founded in 2000 and is based in Holte, Denmark.
Nxt2b is a venture capital company focused on investments in healthcare, pharmaceuticals companies, and medical devices.
Show more
Investment focus
- Health Care, Biotechnology, Health Diagnostics
- Series A
- Sweden
Portfolio highlights
- Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
Porte Monnaie is an early and active investor for startup companies and passive investors in listed companies with growth potential.
Porte-Monnaie's mission is to invest in Swedish companies.
Show more
Investment focus
- Health Care, Biotechnology
- Seed
- Sweden
Portfolio highlights
- Gedea Biotech — Gedea Biotech develops an antibiotic-free, safe and effective treatment of vaginal fungal infections. Vaginal yeast infections are a major problem that affects about 75% of all women at some point in life. Gedea Biotech's substance, GA101, is a natural substance that has always been part of their environment. It acts by lowering the pH as wellas providing a physical barrier protection and inhibiting biofilm formation. The first product will be a topical treatment of vaginal fungal infections.
Hampus Jakobsson is a General Partner at early stage climate tech venture fund Pale Blue Dot.Prior to co-founding Pale Blue Dot, Hampus was a Venture Partner at science fund Blue Yard and a prolific angel investor with >100 angel investments. He co-founded of The Astonishing Tribe (acquired by Blackberry in 2010 for $150m). He left Blackberry2012 to found Brisk.io a sales productivity tool which folded 2016.
Show more
Investment focus
- Health Care, Software, Mobile
- Seed, Angel, Series A
- Sweden, Denmark, United States
Portfolio highlights
- ClimateView — ClimateView is a Swedish climate action technology company that helps cities transform climate planning into progress. We combine data, agent-based modelling and interface design to help cities successfully manage the transition to zero carbon economies.
- Mojo — Clinical-grade, AI-powered sperm analysis from the comfort of home. Test your sperm count, motility, morphology and much more with the Mojo kit. Check your fertility from home at low cost - without the need for clinic visits and awkward waiting rooms.
- Volta Greentech — Battling global warming by reducing methane emissions from cows
Bonnier Capital is the investment division of the Bonnier Group. Since 2016, we invest in promising companies in structurally growing industries and have become a reliant investment partner to companies and funds of various sizes.
Show more
Investment focus
- Health Care, Digital Media, Software
- Funding Round, Seed, Series A
- Sweden, Finland, Germany
Portfolio highlights
- Combify — Combify is a PropTech company that works with simplifying the communication in city development projects.
- Natural Cycles — Natural Cycles birth control is 93% effective with typical use and 98% effective with perfect use. Learn more about hormone-free birth control today.
- Kyra — Kyra is a Gen-Z entertainment company creating engaging digital content that resonates with youth culture. We represent world class digital native talent, produce digital content with the biggest and best consumer brands and develop media properties publishing daily content on platforms that matter to Gen Z. Kyra has the ability to not onlytarget but truly engage with the Gen-Z audience through content that resonates based on real-time audience data from our proprietary KyraIQ technology. Our inclusive, ahead-of-the-trend content and content creators make us the ultimate destination for the Gen-Z consumer who wants to be inspired by their own community. Our approach and creativity is based on data and insights and has proven to engage this audience better than any traditional publisher. We house a talent agency representing and collaborating with the leading Gen Z social stars such as Abby Roberts and Noen Eubanks; a global content studio creating award-winning content for youth-seeking brand partners such as Converse and HP; and a newly developed portfolio of media properties publishing daily content on Gen Z-native platforms around beauty, fashion, adventure, food, gaming and entertainment.Kyra engages Gen Z better than any traditional publisher, with an audience of 78 million social media followers racking up 750 million monthly video views in 190 countries around the globe. We know exactly where Gen Z is spending their time online and we respect their interests and passions. That result is content that is meaningful and fosters long term engagement for blue chip brands. Our team are experts on Gen Z culture, whether they are producing, managing, creating or marketing in New York, London and Los Angeles. Learn more at https://kyra.com/reel
Simon Fredriksson is the Co-Founder and CEO of Pixelgen Technologies. He attended Stanford University School of Medicine in 2003.
Show more
Investment focus
- Biotechnology, Medical, Genetics
- Seed
- Sweden
Portfolio highlights
- SAGA Diagnostics — SAGA Diagnostics is revolutionizing the earlier detection of Molecular Residual Disease (MRD) to help inform personalized treatment.
- Pixelgen Technologies — Understand the role of proteins in cellular organization with spatial proteomics. Get ahead in the field of proteomics with us.
SmiLe Inject Capital is an angel investment company to focus exclusively on early-stage life science companies.
Show more
Investment focus
- Medical, Genetics, Analytics
- Seed
- Sweden
Portfolio highlights
- Nygen Analytics — Nygen empowers researchers to unlock insights from single-cell RNA-seq data with accessible, no-code solutions, facilitating reproducible transcriptomic research.
A leader in the alternative asset space, TPG was built for a distinctive approach, managing assets through a principled focus on innovation.
Show more
Investment focus
- Health Care, Software, Biotechnology
- Series C, Series B, Private Equity
- United States, India, China
Portfolio highlights
- Fibe — Get instant loans up to Rs. 5L with tenures up to 24 months & rates as low as 2.5% p.m. Check your eligibility now.
- Homrich Berg — Homrich Berg is a personal wealth management firm based in Atlanta, GA helping families protect, grow, and manage their wealth since 1989.
- Dr. Agarwal's — Dr. Agarwals eye hospital with best eye specialist and 135+ hospitals in India providing best eye disease treatment since 1957. Book an appointment now!
Josefin Landgård is the Founder and CEO of Mantle. Previously she served as the Co-Founder and COO at KRY back in March 2014 to September 2018.
Show more
Investment focus
- Health Care, Medical, Women's
- Seed, Angel, Pre-Seed
- Sweden, France
Portfolio highlights
- Estmn — Estrid is an online portal that offers women's personal care products.
- Lassie — Lassie is the first proactive and preventive pet insurance company that wants to help pet owners take better care of their pets
- Elsa — Elsa is a platform for patient driven research for better drugs, health and prevention. Elsa lets patients become their own personal researchers by providing them with a better understanding around how lifestyle factors may affect their disease activity measurements for chronic disease. To support them from a scientific perspective, Elsa gives themaccess to data on their specific disease (initially we work with rheumatoid arthritis) through the Riskminder foundation and scientific studies at Karolinska Institutet.
Inter IKEA Group's aim is to secure continuous improvement, development, expansion and a long life of the franchising operation.
Show more
Investment focus
- Software, Furniture, Health Care
- Funding Round, Seed, Corporate Round
- Germany, Sweden, Denmark
Portfolio highlights
- nyris — Our custom search engines make it easy for people to find products, spare parts, and components for industry and eCommerce
- NORNORM — High quality pre-loved office furniture, including office design, installation and flexibility to change. Own less, pay less, and change whenever.
- Seprify — Enabling sustainable products
Fibonacci Growth Capital is a venture capital investment firm.
Show more
Investment focus
- Biotechnology, Manufacturing, Medical Device
- Seed
- Sweden
Portfolio highlights
- Pixelgen Technologies — Understand the role of proteins in cellular organization with spatial proteomics. Get ahead in the field of proteomics with us.
LU Holding is a Lund University’s investment company.
Show more
Investment focus
- Biotechnology
- Pre-Seed
- Sweden
Portfolio highlights
- Trackpaw Scientific — Contributing to the development of safe and effective pharmaceuticals at increased speed and quality by digitalising the preclinical study landscape.
European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union.The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds;equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds.The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises.EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors.European Investment Bank was founded in 1958 and is based in Luxembourg.
Show more
Investment focus
- Biotechnology, Health Care, Energy
- Debt Financing, Post-IPO Debt, Funding Round
- France, Germany, The Netherlands
Portfolio highlights
- BURN — The future of clean cooking
- GEWOBA — GEWOBA is a real estate company that manages and provides a diverse portfolio of rental real estate apartments and properties.
- Acea — Acea operates in six business segments. The water segment collects, purchases, transports and distributes drinking water, and manages the sewerage system and the purification of wastewaters. The company serves 9 million residents served in Lazio, Tuscany, Umbria, Molise and Campania; The energy segment manages the transmission and distributesroughly 9 TWh of electricity, public lighting; commercial and trading segment activities include energy management, sale of electricity and gas, energy efficiency for domestic customers. The company is targeting growth in electricity generation from renewable (photovoltaic) sources and in electric mobility, with a view to effectively contributing more and more to the energy transition and decarbonisation. The environment segment provides laboratory, research and related consultancy services on the environment and control functions within the water cycle; engineering services and overseas operations providing water services in Latin America.
Landegren Gene Technology
Show more
Investment focus
- Health Care, Biotechnology, Health Diagnostics
- Series A
- Sweden
Portfolio highlights
- Navinci Diagnostics — Navinci is a Swedish biotech company specializing in innovative in situ proximity ligation assay-based solutions for spatial proteomics.
Länsförsäkringar is a Swedish group of public insurance companies.
Show more
Investment focus
- Manufacturing, Apps, Mobile
- Seed, Funding Round
- Sweden
Portfolio highlights
- Wrapp — THE NEW STANDARD HAS ARRIVED. Wrapp is The New Standard for rewarding purchases and customer loyalty. The end to an era of irrelevant advertising and outdated memberships. Wrapp connects to our users’ payment cards, and analyzes transactions to learn their buying behavior. This way, our users only get rewards from brands they're interestedin. And by sticking to cashback returns, we make sure they get rewards they actually find useful. Simply put, we put purchasing power in the hands of consumers, and meaningful marketing in the hands of brands.
- Altris — Altris is a leading developer of sodium-ion batteries, offering superior performance and sustainability. Our innovative energy storage solutions are made from abundant and renewable materials, revolutionizing the way we power the world. Discover our cutting-edge technology today.
- Vindmark — Innovativ effektiv vindkraft
Investors by industry
Biotech
Proptech
Gaming
FinTech
Health Care
Community
Google
Marketplace
Climate
Consumer
Artificial intelligence
Impact
Energy
Hardware
EdTech
Sustainability
Venture Capital
Clean Energy
B2B
Real Estate
Publishing
Payments
Big Data
Retail
Organic Food
Web3
Education
Finance
Food and Beverage
Video Games
Infrastructure
Financial Services
Photography
Beauty
Medical
Wellness
Social Media
Social Network
Android
Construction
Art
Local
Legal
Digital Media
Manufacturing
eSports
Sports
Music
Mobile
Internet
Enterprise Software
Franchise
Email
Travel
Mobile Advertising
Biotechnology
Recruiting
Hospitality
Fitness
Platforms
Cannabis
Medical Device
Social
Automotive
Crowdfunding
Wine And Spirits
CleanTech
Mobile Apps
Transportation
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Film
Theatre
Non Profit
Renewable Energy
SaaS
Sporting Goods
Social Impact
Restaurants
Software
Celebrity
Cryptocurrency
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
India
Germany
South Korea
United Kingdom
Australia
Canada
New Zealand
Ireland
United States
Qatar
Saudi Arabia
Spain
Sri Lanka
China
Middle East
Africa
Indonesia
Europe
Armenia
Singapore
Oceania
Brazil
Japan
South Africa
Vietnam
LATAM
Asia
Denmark
Costa Rica
Bermuda
Egypt
Croatia
Gibraltar
Algeria
Estonia
Ecuador
Greece
Chile
Bulgaria
Lebanon
Mali
Liberia
Malta
Liechtenstein
Malaysia
Italy
Panama
Myanmar
Mauritius
Nicaragua
Philippines
Lithuania
Israel
Jersey
Norway
Morocco
Mexico
Peru
Kuwait
Puerto Rico
Tunisia
Uganda
Sierra Leone
Senegal
San Marino
Uzbekistan
Seychelles
Togo
El Salvador
Rwanda
Russian Federation
Tanzania
Ukraine
Zimbabwe
Uruguay
Serbia
Taiwan
Venezuela
Tajikistan
Sweden
Turkey
Poland
Thailand
Zambia
Portugal
Slovenia
Dominican Republic
Azerbaijan
Iraq
Iceland
Bahamas
Namibia
Nigeria
United Arab Emirates
Jamaica
Honduras
Bolivia
Isle of Man
Luxembourg
Albania
Pakistan
Bangladesh
Argentina
Grenada
Jordan
Romania
Ethiopia
Hong Kong
Faroe Islands
France
Ghana
Czech Republic
Hungary
Georgia
Belgium
Finland
Bahrain
Belarus
Belize
Barbados
Kenya
Kazakhstan
Cayman Islands
Cambodia
Cameroon
Cyprus
Latvia
Oman
Austria
Switzerland
Colombia
Marshall Islands
Guatemala
Investors in Sweden by industry
Restaurants
Crowdfunding
Artificial intelligence
Sporting Goods
Financial Services
Big Data
Cryptocurrency
Finance
Payments
Organic Food
Social
Video Games
Food and Beverage
Medical Device
Biotechnology
Wellness
Internet
Social Media
Art
Manufacturing
Digital Media
Music
Mobile
Android
Blockchain
Legal
Construction
Social Network
Software
Enterprise Software
Sports
eSports
Fitness
Hospitality
CleanTech
Travel
InsurTech
FinTech
Enterprise
Consumer
Health Care
Sustainability
EdTech
Climate
Energy
SaaS
Impact
Proptech
Marketplace
Hardware
Retail
Infrastructure
Beauty
Web3
B2B
Life Science
Photography
Publishing
Education
Clean Energy
Recruiting
Platforms
Real Estate
Automotive
Biotech
Community
Wine And Spirits
Gaming
Mobile Apps
Transportation
Email
Fashion
Agriculture (agtech)
Social Impact
Medical
Media (entertainment)
Renewable Energy